A press release by Intellectual Venture stated that this transaction follows the acquisition of formerly publicly traded Transmeta by privately held Novafora Inc.

With this transaction, Intellectual Venture Funding LLC acquired more than 140 US patents and a substantial number of pending patent applications.

The transaction also includes patents and patent applications in countries beyond the United States.

With the completion of these two transactions, the technology developed by Transmeta for more than a decade will be used further through two distinct routes:

1) Novafora’s improving its own proprietary designs by using some of the technologies invented by Transmeta, and
2) Intellectual Ventures providing other companies with access to Transmeta’s former patent rights under non-exclusive licensing terms.

“This transaction demonstrates how Intellectual Ventures’ unique business model can enhance the creation, dissemination, and use of technological inventions,” said Vincent Pluvinage, PhD, who leads strategic Intellectual Property acquisitions and private equity partnerships at Intellectual Ventures.

“When technologies from multiple sources are combined, or when patent rights from many inventors are combined, the original inventions can now find a home in new applications and in new companies,” he added.

This portfolio contains relatively young patents; many were issued in the last few years. Transmeta licensed these patents to several of the largest microprocessor companies to generate revenue of approximately $300 million.

SOURCE:AGIPNEWS